These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID). Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039 [TBL] [Abstract][Full Text] [Related]
3. Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam. Herrmann WM; Stephan K Int Psychogeriatr; 1992; 4(1):25-44. PubMed ID: 1391670 [TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Kanowski S; Hoerr R Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of xantinolnicotinate in patients with dementia. Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635 [TBL] [Abstract][Full Text] [Related]
6. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study. Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138 [TBL] [Abstract][Full Text] [Related]
7. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021 [TBL] [Abstract][Full Text] [Related]
8. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome. Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366 [TBL] [Abstract][Full Text] [Related]
9. EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID. Saletu B; Anderer P; Fischhof PK; Lorenz H; Barousch R; Böhmer F Biol Psychiatry; 1992 Oct; 32(8):668-81. PubMed ID: 1457622 [TBL] [Abstract][Full Text] [Related]
10. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R Phytomedicine; 1997 Mar; 4(1):3-13. PubMed ID: 23195239 [TBL] [Abstract][Full Text] [Related]
11. A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. Marcusson J; Rother M; Kittner B; Rössner M; Smith RJ; Babic T; Folnegovic-Smalc V; Möller HJ; Labs KH Dement Geriatr Cogn Disord; 1997; 8(5):320-8. PubMed ID: 9298634 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT). Rüther E; Ritter R; Apecechea M; Freytag S; Windisch M Pharmacopsychiatry; 1994 Jan; 27(1):32-40. PubMed ID: 8159781 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial. Ditzler K Arzneimittelforschung; 1991 Aug; 41(8):773-80. PubMed ID: 1781796 [TBL] [Abstract][Full Text] [Related]
14. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study. Weyer G; Eul A; Milde K; Wierich W; Herrmann WM Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459 [TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type]. Haase J; Halama P; Hörr R Z Gerontol Geriatr; 1996; 29(4):302-9. PubMed ID: 8974721 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; Int J Geriatr Psychiatry; 2011 Nov; 26(11):1186-94. PubMed ID: 21140383 [TBL] [Abstract][Full Text] [Related]
18. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Mazza M; Capuano A; Bria P; Mazza S Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364 [TBL] [Abstract][Full Text] [Related]
19. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study. Görtelmeyer R; Erbler H Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054 [TBL] [Abstract][Full Text] [Related]
20. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial. Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]